Congress investigates how pharma middlemen affect drug prices
House Republicans are investigating pharmacy-benefit managers, middlemen in drug price negotiations, over whether they create unnecessary costs for prescription drugs.
UPS employees in Texas charged with trafficking cocaine
Two UPS employees are part of a group of five accused of trafficking cocaine in southern Texas. Law enforcement seized approximately 60 kilograms of cocaine.
Opioid antidote Narcan should be available over the counter, FDA panel says
A panel urged the FDA to give final approval to a plan that would make Narcan, the nasal version of the overdose-reversal drug naloxone, available over the counter.
Twitter now allows cannabis companies to advertise
Twitter has updated its policies to allow cannabis companies to advertise on the platform, becoming the first major social media company to roll out the option.
US Appeals Court sides with drugmakers on discount program
Drugmakers win battle in Third Circuit Court of Appeals over Health Resources and Services Administration, as courts decided HRSA went beyond the law with regulatory overreach.
FDA calls on Congress to create new regulations for hemp-derived CBD products
The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.
Juul in deal talks with three tobacco giants
Juul is looking for a new backer as FDA order banning its vaporette remains in limbo pending trial. Talks have included Philip Morris, Japan Tobacco Group, and Altria.
Johnson & Johnson fourth-quarter earnings down 25%
The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.
FDA rejects Lilly’s alzheimer’s drug candidate, seeks more data
Lilly said it would work with the FDA to evaluate the fastest pathway to get its Alzheimer’s drug to market after what it believes was a successful trial.
Oklahoma announces another $226 million in settlements over opioid epidemic
Oklahoma announced new settlements totaling $226.1 million with three pharmacy chains and a drug manufacturer over the opioid epidemic on Wednesday.
New York's first legal weed shop opens, officials hope budding industry will be tax revenue boon
New York's first legal recreational marijuana dispensary, Housing Works Cannabis Co, opened in Lower Manhattan on Thursday, with dozens of others on the way.
Greater Boston company deploys under-vehicle scanners to catch fentanyl, human traffickers at US border
Boston area company Viken Detection is providing Customs and Border Protection under-vehicle scanners at dozens of points of entry along the U.S. southern border.
San Francisco not safe for tourists: Mothers Against Drug Deaths co-founder
Jacqui Berlinn describes how fentanyl has corrupted San Francisco and the path it takes out of the city on 'Tucker Carlson Tonight.'
Narcan maker gets fast-tracked for over-the-counter nasal spray
FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.
FDA takes tougher line on fast-tracked drugs
The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.
Portlanders flock to store to buy illegal psychedelic mushrooms: 'A part of history'
Long lines have formed outside of Portland, Oregon's Shroom House, as patrons wait to buy psilocybin. Recreational psychedelic mushroom sales are still illegal, however.
Walmart offers to pay $3.1B to settle opioid lawsuits
Walmart is the latest company to announce a settlement with local governments over allegations of improperly filling prescriptions for powerful painkillers
CVS reaches $5B settlement of opioid lawsuits, becomes first pharmacy to strike nationwide deal
CVS Health has announced a $5 billion deal that, if approved, would make it the first major pharmacy chain to reach a nationwide settlement of opioid lawsuits.
Blood pressure medication recalled due to chemicals' possible link to cancer
The FDA-recalled quinapril and hydrochlorothiazide tablets were shipped to customers nationwide in May 2021. No related adverse reactions have been reported.
FDA approves Amylyx ALS drug
Amylyx says doctors will be able to prescribe Relyvrio immediately. The drugmaker anticipates prescriptions will be filled and shipped from specialty pharmacies within the next four to six weeks.